can you tell me how to choose a pt for harmony CA for anti aging
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
can you tell me how to choose a pt for harmony CA for anti aging
Asking for Preferences
Reading File
Searching the Web
Calcium Hydroxylapatite CaHA Radiesse patient selection anti-aging criteria
Searching PubMed
calcium hydroxylapatite filler patient selection anti-aging
Here is a practical, evidence-based guide to selecting the right patient for Calcium Hydroxylapatite (CaHA / Radiesse) anti-aging treatment:
Patient Selection for CaHA (Radiesse) Anti-Aging Treatment
Who Is the Ideal Candidate?
CaHA is appropriate for patients across a broad age spectrum, structured into three general groups (JCAD, Van Loghem et al.):
| Age Group | Goal |
|---|---|
| 25-35 years | Early prevention, youthful enhancement |
| 35-55 years | Rejuvenation, volume restoration |
| 55-75+ years | Delay, maintenance, restoration |
Positive Selection Criteria (Good Candidates)
1. Signs of Facial Aging Present
- Mild to moderate volume loss (cheeks, temples, midface)
- Nasolabial folds, marionette lines, jawline laxity
- Skin laxity and early rhytids (wrinkles)
- Loss of facial contour over bony prominences
2. Skin Type
- Fitzpatrick skin types I-IV are well studied (MDPI, 2025)
- Types V-VI can be treated but require more caution regarding post-inflammatory changes
3. Patient Goals
- Seeking volumization AND collagen stimulation (long-term biostimulation effect)
- Preferring longer-lasting results (12-18 months in mobile areas; up to 24 months over bony prominences)
- Realistic expectations about outcomes and gradual improvement
4. Areas Best Suited for CaHA
- Cheeks / malar region
- Nasolabial folds
- Marionette lines
- Jawline and chin
- Temples
- Hands (FDA-approved)
- Hyperdiluted CaHA is also excellent for skin quality improvement on the neck, decolletage, and body
Contraindications / Who to Avoid (Exclusion Criteria)
| Absolute | Relative / Proceed with Caution |
|---|---|
| Active local infection at treatment site | Prior temporary/semi-permanent fillers in same area (within 12 months) |
| Known allergy to CaHA components or local anesthetic | Darker Fitzpatrick types V-VI (risk of nodules) |
| Pregnancy or breastfeeding | History of keloid scarring |
| Autoimmune or systemic collagen disease | Very thin skin / significant skin atrophy |
| Severe bleeding disorders | Patients on immunosuppressants or NSAIDs |
| Permanent fillers in treatment zone (silicone, PMMA) | Patients with body dysmorphic disorder |
| Unrealistic expectations | |
| Existing keloidal scars |
Key pitfall: CaHA should NOT be injected into the lips or lower periocular/tear trough area - it carries high risk of nodule formation ("speed bump nodules") in these locations. (PMC/NCBI)
Clinical Assessment Checklist
Before treating, evaluate:
- Facial analysis - assess volume loss, proportions, symmetry, skin quality, and which facial thirds are affected
- Skin quality - laxity, thickness, Fitzpatrick type
- Prior filler/treatment history - type, location, and timing of any previous injectables
- Medical history - bleeding disorders, autoimmune disease, allergies, medications
- Realistic expectations - discuss gradual collagen stimulation (full effect seen over 4-8 weeks), not just immediate fill
- Psychological screening - rule out body dysmorphic disorder
Why CaHA is Particularly Attractive for Anti-Aging
- Dual mechanism: immediate volumization + biostimulation (fibroblast activation, new collagen/elastin production)
- The scaffold formed as CaHA microspheres degrade stimulates long-term structural skin improvement
- Fully biocompatible (same mineral as bone/teeth), biodegradable, non-antigenic - low allergy risk
- Results reviewed in a 2024 systematic review (PMID: 38390986) confirm safety and efficacy across body indications, and a 2023 systematic review (PMID: 37332763) on skin regeneration mechanisms confirms the collagen-stimulating action.
Summary
The ideal CaHA anti-aging patient is an adult with mild-to-moderate facial aging, realistic goals, no active infection or autoimmune disease, no permanent fillers in the area, and is not pregnant. They should want both volume correction and skin quality improvement, and be comfortable with a gradual biostimulation response over weeks to months.
This is a shared conversation. Sign in to Orris to start your own chat.